Complications 18 years after polyacrylamide hydrogel augmentation mammoplasty: a case report and histopathological analysis. Issue 6 (22nd June 2021)

• Record Type: Journal Article
• Authors: DeLuca, Matthew; Shapiro, Alexandra; Banayan, Elliot; Zielinski, Gregory; Karanetz, Irena; Asarian, Armand; Xiao, Philip
• Is Part Of: Journal of surgical case reports. Volume 2021:Issue 6(2021)
• Publication Date: 2021-06-22
• Subjects: Surgery -- Periodicals; Surgery -- Case studies -- Periodicals; 617.005
• DOI: 10.1093/jscr/rjab276
• Languages: English
• ISSNs: 2042-8812

Abstract

Abstract: Polyacrylamide hydrogel (PAAG) is a synthetic substance previously used as an injectable material for augmentation mammoplasty. Current literature has demonstrated that the average time from PAAG injection to the onset of complication ranges from 6 to 39 months. We present a unique case report describing the onset of complications 18 years after PAAG augmentation mammoplasty. To the best of our knowledge, the presentation of a healthy female who experienced unprovoked expansion of breast tissue >15 years after polyacrylamide injection has not been previously reported in surgical literature. This suggests that serious complications of PAAG injection may occur later than the literature has previously described. Importantly, this case is the first demonstration of the successful surgical removal of polyacrylamide 18 years after injection. Additionally, this case also provides a histopathological analysis of breast capsules which showed evidence of an extensive chronic inflammatory reaction to polyacrylamide, consistent with previous reports.